Myositis Clinical Trials in Paris
6 recruitingParis, France
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Lupus Nephritis+2 more
Fate Therapeutics244 enrolled18 locationsNCT06308978
Recruiting
Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Pfizer318 enrolled147 locationsNCT05895786
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
AstraZeneca240 enrolled234 locationsNCT06455449
Recruiting
Phase 3
Baricitinib in Patients With Relapsing or naïve Dermatomyositis
Dermatomyositis
Assistance Publique - Hôpitaux de Paris62 enrolled1 locationNCT04972760
Recruiting
Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
Inflammatory MyositisIdiopathic Inflammatory MyositisDrug-induced Inflammatory Myositis
Assistance Publique - Hôpitaux de Paris4,000 enrolled2 locationsNCT05454527
Recruiting
Phase 2
Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
DermatomyositisSystemic SclerosisiPPSD2
University Hospital, Limoges40 enrolled8 locationsNCT03582800